These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 3043348

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of intravenous and intraperitoneal fosfomycin in continuous ambulatory peritoneal dialysis.
    Bouchet JL, Albin H, Quentin C, de Barbeyrac B, Vinçon G, Martin-Dupont P, Potaux L, Aparicio M.
    Clin Nephrol; 1988 Jan; 29(1):35-40. PubMed ID: 3383462
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
    Mars RL, Moles K, Pope K, Hargrove P.
    Adv Perit Dial; 2000 Jan; 16():280-4. PubMed ID: 11045311
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of intraperitoneal piperacillin/tazobactam in patients on peritoneal dialysis with and without pseudomonas peritonitis.
    Zaidenstein R, Weissgarten J, Dishi V, Koren M, Soback S, Gips M, Averbuch Z, Simantov R, Assulin E, Golik A.
    Perit Dial Int; 2000 Jan; 20(2):227-31. PubMed ID: 10809248
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Systemic absorption of intraperitoneal antimicrobials in continuous ambulatory peritoneal dialysis.
    O'Brien MA, Mason NA.
    Clin Pharm; 1992 Mar; 11(3):246-54. PubMed ID: 1611814
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Disposition of ceftazidime after intraperitoneal administration in adolescent patients receiving continuous cycling peritoneal dialysis.
    Sisterhen LL, Stowe CD, Farrar HC, Blaszak CK, Blaszak RT.
    Am J Kidney Dis; 2006 Mar; 47(3):503-8. PubMed ID: 16490630
    [Abstract] [Full Text] [Related]

  • 15. [Absorption of ceftizoxime from peritoneal dialysate and its pharmacokinetics in chronic kidney failure patients].
    Gao S, Li P, Liu GL, Wang SX, Chui RL, Yang JP.
    Zhongguo Yao Li Xue Bao; 1992 Jul; 13(4):377-80. PubMed ID: 1456067
    [Abstract] [Full Text] [Related]

  • 16. [The effect of the number of peritonitis episodes on peritoneal membrane function].
    Jovanović D, Nesić V, Dimitrijević Z.
    Srp Arh Celok Lek; 1999 Jul; 127(1-2):28-31. PubMed ID: 10377837
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration?
    Roberts JA, Roberts MS, Robertson TA, Dalley AJ, Lipman J.
    Crit Care Med; 2009 Mar; 37(3):926-33. PubMed ID: 19237898
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.